MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue6/30/20196/30/20186/30/20176/30/2016
Total Revenue851,100743,700728,700740,500
Cost of Revenue201,000177,200171,200157,300
Gross Profit650,100566,500557,500583,200
Operating Expenses
Research Development85,90070,80074,40070,600
Selling General and Administrative534,700435,000439,900359,200
Non Recurring----
Others----
Total Operating Expenses821,600683,000685,500587,100
Operating Income or Loss29,50060,70043,200153,400
Income from Continuing Operations
Total Other Income/Expenses Net-29,50059,400-7,0002,600
Earnings Before Interest and Taxes29,50060,70043,200153,400
Interest Expense-12,000-3,200-6,000-300
Income Before Tax-120,10036,200156,000
Income Tax Expense-4,400-13,00019,00038,800
Minority Interest---400-400
Net Income From Continuing Ops4,400133,10017,200117,200
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,600133,30017,400117,200
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,600133,30017,400117,200